• 11.4.3 |
INDIA............................................................................................................................................................ 122 |
|||
• 11.4.3.1 |
EMERGENCE OF LOCAL PLAYERS IN INDIA BACKED BY FUNDING FROM |
|||
THE GOVERNMENT................................................................................................................ 122 | ||||
• 11.4.4 |
JAPAN.......................................................................................................................................................... 124 |
|||
• 11.4.4.1 |
COLLABORATIONS BETWEEN KEY GLOBAL AND LOCAL PLAYERS...................................... 124 |
|||
• 11.4.5 |
REST OF ASIA-PACIFIC............................................................................................................................... 127 |
|||
• 11.4.5.1 |
ALLIANCES AND PARTNERSHIPS IN THE GENOMICS MARKET TO BOOST |
|||
THE AUSTRALIAN MARKET.................................................................................................... 127 | ||||
• 11.5 |
REST OF THE WORLD( ROW)......................................................................................................................................... 129 |
|||
• 11.5.1 |
MIDDLE EAST AND AFRICA......................................................................................................................... 132 |
|||
• 11.5.1.1 |
SAUDI HUMAN GENOME PROJECT....................................................................................... 132 |
|||
• 11.5.2 |
LATIN AMERICA........................................................................................................................................... 134 |
|||
• 11.5.2.1 |
INVESTMENTS IN RESEARCH AND INNOVATION CENTERS |
|||
AND CONFERENCES & WORKSHOPS IN BRAZIL.................................................................. 134 | ||||
12 |
COMPETITIVE LANDSCAPE..................................................................................................... 137 |
|||
• 12.1 |
OVERVIEW...................................................................................................................................................................... 137 |
|||
• 12.2 |
MARKET SHARE ANALYSIS........................................................................................................................................... 138 |
|||
• 12.2.1 |
ILLUMINA, INC.( U. S.)................................................................................................................................. 138 |
|||
• 12.2.2 |
BEIJING GENOMICS INSTITUTE( CHINA).................................................................................................... 140 |
|||
• 12.2.3 |
EUROFINS GENOMICS( GERMANY)............................................................................................................ 141 |
|||
• 12.2.4 |
QIAGEN N. V.( NETHERLANDS).................................................................................................................... 142 |
|||
• 12.2.5 |
THERMO FISHER SCIENTIFIC, INC.( U. S.).................................................................................................. 143 |
|||
• 12.2.6 |
AGILENT TECHNOLOGIES, INC.( U. S.)........................................................................................................ 144 |
|||
• 12.2.7 |
AFFYMETRIX, INC.( U. S.)............................................................................................................................ 145 |
|||
• 12.2.8 |
OTHER PLAYERS.......................................................................................................................................... 145 |
|||
• 12.3 |
COMPETITIVE SITUATION AND TRENDS....................................................................................................................... 146 |
|||
• 12.3.1 |
NEW PRODUCT LAUNCHES........................................................................................................................ 147 |
|||
• 12.3.2 |
AGREEMENTS, CONTRACTS, PARTNERSHIPS, AND COLLABORATIONS................................................... 148 |
|||
• 12.3.3 |
ACQUISITIONS............................................................................................................................................. 149 |
|||
• 12.3.4 |
EXPANSIONS............................................................................................................................................... 150 |
|||
• 12.3.5 |
OTHER DEVELOPMENTS............................................................................................................................. 151 |
|||